Cargando…
FBP1 induced by β‐elemene enhances the sensitivity of gefitinib in lung cancer
BACKGROUND: β‐elemene is known to play a critical role in tumorigenesis as well as tyrosine kinase inhibitor (TKI) resistance in lung cancer. However, the biological function and molecular mechanism remain largely unknown. METHODS: In this study, the common genes involved in gefitinib resistance and...
Autores principales: | Li, Jian, Dai, Ping, Sun, Jing, Yu, Wenyan, Han, Wei, Li, Kaichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891864/ https://www.ncbi.nlm.nih.gov/pubmed/36525508 http://dx.doi.org/10.1111/1759-7714.14750 |
Ejemplares similares
-
β-Elemene Synergizes With Gefitinib to Inhibit Stem-Like Phenotypes and Progression of Lung Cancer via Down-Regulating EZH2
por: Cheng, Haibo, et al.
Publicado: (2018) -
The mechanism of m(6)A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene
por: Liu, Shuiping, et al.
Publicado: (2020) -
β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1
por: Zhang, Shaochun, et al.
Publicado: (2021) -
Anti-Lung-Cancer Activity and Liposome-Based Delivery Systems of β-Elemene
por: Chen, Meiwan, et al.
Publicado: (2012) -
Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
por: Zhai, Bingtao, et al.
Publicado: (2018)